Clinical Trial Update: Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction [Phase 1]

View source ↗

Summary

This clinical trial update covers a Phase 1 study of oxaliplatin for treating advanced cancers in patients with liver dysfunction, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Liver Disease | Phase 1 | Status: COMPLETED